Expand / Collapse search
Watch TV
☰

Quotes displayed in real-time or delayed by at least 15 minutes. Market data provided by Factset. Powered and implemented by FactSet Digital Solutions.  Legal Statement.

This material may not be published, broadcast, rewritten, or redistributed. ©2026 FOX News Network, LLC. All rights reserved. FAQ - New Privacy Policy

cry cell intl - CCEL

CCEL

Close Chg Chg %
3.67 -0.26 -6.96%

Pre-Market

3.41

-0.26 (6.96%)

Volume: 6.82K

Last Updated:

Apr 17, 2026, 2:47 PM EDT

Trade Now

Company Overview: cry cell intl - CCEL

CCEL Key Data

Open

$3.64

 Day Range

3.41 - 3.67

52 Week Range

2.72 - 6.35

 Market Cap

$29.16M

Shares Outstanding

8.06M

 Public Float

3.79M

Beta

0.63

 Rev. Per Employee

N/A

P/E Ratio

N/A

 EPS

-$0.33

Yield

1,104.97%

 Dividend

$0.15

EX-DIVIDEND DATE

May 21, 2025

 SHORT INTEREST

N/A

AVERAGE VOLUME

16.39K

  

CCEL Performance

1 Week
 
 0.00%
 
1 Month
 
 10.26%
 
3 Months
 
 0.88%
 
1 Year
 
 -40.89%
 
5 Years
 
 -65.25%
 

CCEL Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 1
Full Ratings ➔

About cry cell intl - CCEL

Cryo-Cell International, Inc. is a cord blood bank, which engages in providing stem cell cryopreservation services and advancing regenerative medicine. It operates through the following segments: Umbilical Cord Blood and Cord Tissue Stem Cell Service, PrepaCyte CB, and Public Cord Blood Banking. The Umbilical Cord Blood and Cord Tissue Stem Cell Service segment refers to cellular processing and cryogenic storage of umbilical cord blood and cord tissue stem cells for family use. The PrepaCyte CB segment focuses on the manufacture of PrepaCyte CB units, the processing technology used to process umbilical cord blood stem cells. The Public Cord Blood Banking segment relates to the cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company was founded in 1989 and is headquartered in Oldsmar, FL.

CCEL At a Glance

Cryo-Cell International, Inc.
700 Brooker Creek Boulevard
Oldsmar, Florida 34677
Phone 1-813-749-2100 Revenue 31.57M
Industry Other Transportation Net Income -2,429,385.00
Sector Transportation Employees 76
Fiscal Year-end 11 / 2026
View SEC Filings

CCEL Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 1.099
Price to Book Ratio N/A
Price to Cash Flow Ratio 6.33
Enterprise Value to EBITDA 23.214
Enterprise Value to Sales 1.361
Total Debt to Enterprise Value 0.269

CCEL Efficiency

Revenue/Employee 415,346.329
Income Per Employee -31,965.592
Receivables Turnover 4.611
Total Asset Turnover 0.499

CCEL Liquidity

Current Ratio 0.594
Quick Ratio 0.573
Cash Ratio 0.167

CCEL Profitability

Gross Margin 74.251
Operating Margin 1.528
Pretax Margin -7.404
Net Margin -7.696
Return on Assets -3.844
Return on Equity N/A
Return on Total Capital 34.473
Return on Invested Capital N/A

CCEL Capital Structure

Total Debt to Total Equity N/A
Total Debt to Total Capital -164.015
Total Debt to Total Assets 18.725
Long-Term Debt to Equity N/A
Long-Term Debt to Total Capital -122.668
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Cry Cell Intl - CCEL

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
30.34M 31.34M 31.99M 31.57M
Sales Growth
+5.03% +3.32% +2.05% -1.31%
Cost of Goods Sold (COGS) incl D&A
9.91M 9.57M 8.43M 8.13M
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
1.81M 1.71M 1.02M 1.37M
Depreciation
1.71M 1.61M 953.60K 1.31M
Amortization of Intangibles
96.00K 96.00K 68.00K 58.00K
COGS Growth
+0.89% -3.48% -11.87% -3.60%
Gross Income
20.42M 21.78M 23.55M 23.44M
Gross Income Growth
+7.16% +6.62% +8.16% -0.50%
Gross Profit Margin
+67.33% +69.48% +73.64% +74.25%
2022 2023 2024 2025 5-year trend
SG&A Expense
15.97M 18.29M 19.76M 18.60M
Research & Development
384.79K 1.17M 1.24M 376.26K
Other SG&A
15.58M 17.12M 18.52M 18.22M
SGA Growth
+8.79% +14.54% +8.08% -5.90%
Other Operating Expense
- - 3.74M 4.36M
-
Unusual Expense
28.11K 11.88M (871.14K) 806.27K
EBIT after Unusual Expense
4.43M (12.13M) 4.66M (323.87K)
Non Operating Income/Expense
409.02K 3.44K 6.58K 52.98K
Non-Operating Interest Income
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
1.52M 1.24M 1.86M 2.07M
Interest Expense Growth
+10.36% -18.73% +50.77% +10.81%
Gross Interest Expense
1.52M 1.24M 1.86M 2.07M
Interest Capitalized
- - - -
-
Pretax Income
3.32M (13.36M) 2.80M (2.34M)
Pretax Income Growth
+27.10% -502.67% +120.98% -183.35%
Pretax Margin
+10.94% -42.64% +8.77% -7.40%
Income Tax
547.54K (3.84M) 2.40M 92.23K
Income Tax - Current - Domestic
2.28M 2.91M 2.71M 2.91M
Income Tax - Current - Foreign
- - - -
-
Income Tax - Deferred - Domestic
(1.73M) (6.75M) (308.97K) (2.82M)
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
2.77M (9.52M) 402.10K (2.43M)
Minority Interest Expense
- - - -
-
Net Income
2.77M (9.52M) 402.10K (2.43M)
Net Income Growth
+33.02% -443.57% +104.22% -704.18%
Net Margin Growth
+9.14% -30.38% +1.26% -7.70%
Extraordinaries & Discontinued Operations
- - - -
-
Discontinued Operations
- - - -
-
Net Income After Extraordinaries
2.77M (9.52M) 402.10K (2.43M)
Preferred Dividends
- - - -
-
Net Income Available to Common
2.77M (9.52M) 402.10K (2.43M)
EPS (Basic)
0.3274 -1.1416 0.0494 -0.3011
EPS (Basic) Growth
+27.89% -448.69% +104.33% -709.51%
Basic Shares Outstanding
8.47M 8.34M 8.13M 8.07M
EPS (Diluted)
0.3267 -1.1416 0.049 -0.3011
EPS (Diluted) Growth
+31.10% -449.43% +104.29% -714.49%
Diluted Shares Outstanding
8.48M 8.34M 8.21M 8.07M
EBITDA
6.27M 1.46M 4.81M 1.85M
EBITDA Growth
+37.87% -76.66% +228.85% -61.55%
EBITDA Margin
+20.67% +4.67% +15.05% +5.86%

Snapshot

Average Recommendation HOLD Average Target Price 8.50
Number of Ratings 1 Current Quarters Estimate N/A
FY Report Date 05 / 2026 Current Year's Estimate 0.11
Last Quarter’s Earnings 0.01 Median PE on CY Estimate N/A
Year Ago Earnings -0.30 Next Fiscal Year Estimate 0.02
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 1 1 1 1
Mean Estimate 0.00 0.03 0.11 0.02
High Estimates 0.00 0.03 0.11 0.02
Low Estimate 0.00 0.03 0.11 0.02
Coefficient of Variance N/A N/A N/A N/A

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 0 0 0
OVERWEIGHT 0 0 0
HOLD 1 1 1
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Hold Hold Hold

Insider Actions for Cry Cell Intl - CCEL

Date Name Shares Transaction Value
Jul 11, 2025 Harold D. Berger Director 57,901 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $3.08 per share 178,335.08
Jul 11, 2025 Harold D. Berger Director N/A Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00

Cry Cell Intl in the News